Kennedy Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-26,713
Closed -$1.34M 731
2024
Q1
$1.34M Sell
26,713
-8,622
-24% -$433K 0.03% 589
2023
Q4
$2.13M Buy
+35,335
New +$2.13M 0.05% 479